|
|
 |
 |
|
|
| |
|
| |
The goals of the CMTA STAR initiative are ambitious, yet within reach:- Within five years, introduce effective therapies for the three most common types of CMT
- Within ten years, reverse symptoms of the disorder in some instances
Click here to learn more... |
 |
|
|
|
 |
|
|
| |
|
| |
Charcot-Marie-Tooth Disorder (CMT) is the most commonly inherited peripheral neuropathy, affecting 2.6 million people.
Our mission is to improve the life of everyone affected by CMT, and, with your help, the CMTA funds research, educates doctors and patients, and promotes public awareness of CMT.
Donate now and, thanks to the second $350,000 CMTA Board Challenge, the CMTA Board of Directors will match your contribution, dollar for dollar, up to that amount.
This is an incredible opportunity to help advance CMT research and the work of the CMTA, so please use the button below to get involved and help us achieve our vision of a world without CMT!
|
| |
 |
 |
|
 |
|
 |
|